Viking Therapeutics (VKTX) had the highest return between March 1, 2022 and April 30, 2023 by a mid-cap US stock, returning 536.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Viking Therapeutics (VKTX) | 3/1/2022 - 4/30/2023 | 536.12% |
Torm PLC Class A (TRMD) | 3/1/2022 - 4/30/2023 | 372.79% |
TransMedics (TMDX) | 3/1/2022 - 4/30/2023 | 328.03% |
Verona Pharma PLC ADR (VRNA) | 3/1/2022 - 4/30/2023 | 272.78% |
ELF Beauty (ELF) | 3/1/2022 - 4/30/2023 | 253.91% |
Madrigal Pharmaceuticals (MDGL) | 3/1/2022 - 4/30/2023 | 234.8% |
Scorpio Tankers (STNG) | 3/1/2022 - 4/30/2023 | 203.32% |
Tidewater (TDW) | 3/1/2022 - 4/30/2023 | 202.82% |
Immunovant (IMVT) | 3/1/2022 - 4/30/2023 | 190.29% |
Rhythm Pharmaceuticals (RYTM) | 3/1/2022 - 4/30/2023 | 156.29% |
Vista Oil Gas ADR (VIST) | 3/1/2022 - 4/30/2023 | 152.35% |
TG Therapeutics (TGTX) | 3/1/2022 - 4/30/2023 | 148.3% |
Axsome Therapeutics (AXSM) | 3/1/2022 - 4/30/2023 | 148.2% |
Nuvalent (NUVL) | 3/1/2022 - 4/30/2023 | 140.26% |
Weatherford International (WFRD) | 3/1/2022 - 4/30/2023 | 128.62% |
Hims Hers Health (HIMS) | 3/1/2022 - 4/30/2023 | 123.75% |
Arcellx (ACLX) | 3/1/2022 - 4/30/2023 | 121.37% |
Tecnoglass (TGLS) | 3/1/2022 - 4/30/2023 | 118.05% |
Biohaven Pharmaceutical (BHVN) | 3/1/2022 - 4/30/2023 | 118% |
Geron (GERN) | 3/1/2022 - 4/30/2023 | 117.7% |
MoonLake Immunotherapeutics (MLTX) | 3/1/2022 - 4/30/2023 | 113.86% |
Miniso Group Holding (MNSO) | 3/1/2022 - 4/30/2023 | 113.04% |
PBF Energy (PBF) | 3/1/2022 - 4/30/2023 | 107.72% |
Modine Manufacturing (MOD) | 3/1/2022 - 4/30/2023 | 107.03% |
ADMA Biologics (ADMA) | 3/1/2022 - 4/30/2023 | 106.79% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
